Everolimus (RAD001) activity in renal and hepatocellular carcinoma cells resistant to sunitinib and sorafenib

被引：0
|
作者：
Serova, Maria [1 ,2 ]
Riveiro, Maria Eugenia [1 ,2 ]
Dokmak, Safi [1 ,2 ]
Faivre, Sandrine [1 ,2 ]
Raymond, Eric [1 ,2 ]
机构：
[1] Beaujon Univ Hosp, RayLab, U728, Clichy, France
[2] Beaujon Univ Hosp, Dept Med Oncol, Clichy, France
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4488
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib
    Juengel, Eva
    Kim, Dana
    Makarevic, Jasmina
    Reiter, Michael
    Tsaur, Igor
    Bartsch, Georg
    Haferkamp, Axel
    Blaheta, Roman A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2015, 19 (02) : 430 - 441
  • [2] THE COMBINATION EVEROLIMUS (RAD001) PLUS SORAFENIB IS SUPERIOR TO SORAFENIB MONOTHERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Piguet, A. -C.
    Radojevic, V.
    Afthinos, M.
    Hora, C.
    Ledermann, M.
    Saar, B.
    Dufour, J. -F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S199 - S199
  • [3] Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma
    Kroog, G. S.
    Feldman, D. R.
    Kondagunta, G. V.
    Ginsberg, M. S.
    Fischer, P. M.
    Trinos, M. J.
    Patil, S.
    Ishill, N. M.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] RAD001 (everolimus)
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 22
  • [5] Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
    Agarwala, Sanjiv S.
    Case, Scott
    ONCOLOGIST, 2010, 15 (03): : 236 - 245
  • [6] Prediction of response to RAD001 (everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines
    Brigette B. Y. Ma
    Vivian W. Y. Lui
    Edwin P. Hui
    Cecilia P. Y. Lau
    Kakiu Ho
    Margaret H. L. Ng
    S. H. Cheng
    Sai-Wah Tsao
    Anthony T. C. Chan
    Investigational New Drugs, 2010, 28 : 413 - 420
  • [8] Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: biology and pathways
    Larkin, James M. G.
    Clarke, Rosemary E. J.
    Pickering, Lisa M.
    MEDICAL ONCOLOGY, 2009, 26 : 40 - 45
  • [9] Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: biology and pathways
    James M. G. Larkin
    Rosemary E. J. Clarke
    Lisa M. Pickering
    Medical Oncology, 2009, 26 : 40 - 45
  • [10] Prediction of response to RAD001 (Everolimus) in patients with metastatic renal cell carcinoma
    Seidel, C.
    Fenner, M.
    Merseburger, A.
    Heuser, M.
    Ganser, A.
    Gruenwald, V.
    ONKOLOGIE, 2010, 33 : 105 - 105
12345